The Monash University Centre for Inflammatory Diseases spans basic experimental biology, clinical research and clinical practice in inflammatory diseases.
New research from Dr Cameron Bastow et al. in ICMx
A murine gram‑negative sepsis model with standard care that meets Sepsis‑3 criteria and mirrors clinical pathology. A valuable tool for translational sepsis research. doi.org/10.1186/s40635-026-0…@SCSMonash@MonashCID@cwonglab
ImmuMon is back for 2026!
🗓️ 11th September
📍 Alfred Research Alliance, Innovation & Education Hub
We are currently seeking sponsors, please contact us at immumon@monash.edu to get involved.
Glad to share our recent paper exploring self management strategies in #lupus patients - we need tailored education that promotes patient activation. @SCSMonashsciencedirect.com:5037/scien…
Congratulations to Professors Graeme Polglase and Connie Wong, awarded 2025 @heartfoundation grants for innovative research in newborn resuscitation and stroke-related inflammation.
Their work continues to advance cardiovascular health across the lifespan.
🔗 Read more: bit.ly/3LD1CjM#HeartFoundation#Research#CardiovascularHealth#Monash
Last chance everyone!
Submit your abstract and join the over 55 invited international speakers at the Workshop #vasculitismelbourne2026
Case reports and case series are welcome
And remember the new Young Invstigator Award Session.
See you in 2026!
We’re giving you more time to share your work at the upcoming International Vasculitis Workshop. The new deadline to submit your abstract is 29 September 2025!
Don't miss your opportunity, submit today at vasculitis-melbourne2026.com…
@SCSMonash Monash University/Monash Health is making important advances against Sjögren’s disease in Australia, through establishment of Monash Sjögren Registry. See more about the disease insightplus.mja.com.au/2025/…
Fabulous collaboration between @SCSMonash@MonashCID@Hudson_Research and A/Prof Grant Logan from @CMRI_AUS harnessing gene therapy to deliver therapeutic doses of DNaseI to clear extracellular DNA release from NETs in experimental ANCA Vasculitis.
Extracellular DNA is known to induce inflammation, but does it drive kidney damage in autoimmune vasculitis?
@Kim_M_OS & team @MonashUni report on targeting ecDNA with DNAase I in models of MPO-ANCA vasculitis.
See full report: insight.jci.org/articles/vie…
Extracellular DNA is known to induce inflammation, but does it drive kidney damage in autoimmune vasculitis?
@Kim_M_OS & team @MonashUni report on targeting ecDNA with DNAase I in models of MPO-ANCA vasculitis.
See full report: insight.jci.org/articles/vie…
2 WEEKS TO GO!
Abstract submissions for #ImmuMon2025 close in just TWO WEEKS! Don’t miss your chance to share your latest immunology research with researchers across Monash University.
Abstract Deadline: 15th August
Submit now: immumon.com/registration-abs…
Time is critical in AAV: dampening kidney inflammation prevents damage
Why not target effector T cells - leave other T cells alone?
Our paper in @NDTSocial defines IL-7Ra as a target
doi.org/10.1093/ndt/gfae276
Anti-IL-7Ra Abs are in Phase 2 trials - alopecia @Q32Bio ?an AAV therapy
IL-7Ra signalling in AAV links to relapse/resistance
Our recent paper
🔹defined activated & exhausted T cells in experimental AAV kidneys
🔹neutralised IL-7Ra - a non-depleting mAb - to limit ANCA-associated GN
Similar mAbs are in Phase 2 clinical trials
academic.oup.com/ndt/article…
🚨 Registration and abstract submission for Immumon 2025 is OPEN! ✨
🔗 Download the abstract template and submit before August 15th immumon.com/abstractinstruct…
👉 FREE registration at immumon.com/registration-abs…
𝦩👋 See you at the BDI ⭐️